CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- 4 Planned sale CSO & EVP, Head of Research sold 4,000 shares at an average $321.24 ($1,284,980)
- 4 Open-market sale EVP, Chief Financial Officer sold 2,242 shares at $310.08 ($695,201)
- 4 Open-market sale EVP Chief R&D sold 1,510 shares at an average $362.87 ($547,929)
- 4 Open-market sale Chief Executive Officer sold 9,577 shares at an average $362.86 ($3,475,157)
- 4 Open-market sale EVP, Chief Financial Officer sold 2,780 shares at an average $362.87 ($1,008,766)
- 4 Open-market sale EVP, Chief Commercial Officer sold 1,510 shares at an average $362.87 ($547,927)
- 4 Planned sale CSO & EVP, Head of Research sold 3,800 shares at an average $367.37 ($1,395,992)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Executive Officer acquired 4,697 shares (option exercise)
- 4 Planned sale CSO & EVP, Head of Research sold 12,128 shares at an average $452.18 ($5,483,990)
- 4 Planned sale Chief Executive Officer sold 25,650 shares at an average $452.75 ($11,613,003)
- 4 Grant or award EVP, CLO and Secretary acquired 13,026 shares (grant or award)
- 4 Open-market sale EVP, Chief Financial Officer sold 3,821 shares at an average $452.05 ($1,727,284)
- 4 Open-market sale Chief Executive Officer sold 8,924 shares at an average $452.05 ($4,034,085)
- 4 Open-market sale EVP, Chief Commercial Officer sold 1,405 shares at an average $452.05 ($635,126)
- 4 Open-market sale CSO & EVP, Head of Research sold 2,441 shares at an average $452.05 ($1,103,451)
- 4 Planned sale EVP Chief R&D sold 5,959 shares at an average $451.76 ($2,692,062)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 18,000 shares at an average $467.60 ($8,416,730)
Page 3 of 47 · 936 filings